Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

Clinical trial NCT00220766 · COMPLETED

Trial details

NCT number: NCT00220766
Sponsor: Grifols Therapeutics LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Immunologic Deficiency Syndrome Agammaglobulinemia Severe Combined Immunodeficiency Wiskott-Aldrich Syndrome Common Variable Immunodeficiency

Start date: 2002-08-01
Primary completion: 2002-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.